Suven Life Sciences (SUVEN) Share Price falls 5.13% as Mid Cap pharma stock stays under pressure
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Suven Life Sciences Share Price is trading at Rs 303.60, down 5.13% today, with a market capitalisation of Rs 9,191.76 Cr. The move makes Suven Life Sciences Share Price a clear focus in today’s market update, especially because the stock opened above the previous close of Rs 320 and then weakened through the morning trade. Univest figures confirm the price action, but they do not point to a specific company trigger. That keeps attention on the exact price action, the Mid Cap company profile, and the valuation and profitability picture that investors usually review after a sharp share price decline. As of 01 October 2026 at 1:53:01 PM IST, Suven Life Sciences Share Price remains the key event in the stock’s latest news flow.
For readers tracking Suven Life Sciences Share Price today, the important question is not only where the stock is trading, but what the move says when set against its sector, its peers and its financial ratios. Univest data shows the decline is material enough to place the stock in daily focus, while the underlying fundamentals continue to look stretched on some measures and weak on return ratios.
Suven Life Sciences (SUVEN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 303.6 |
| Previous Close | Rs 320 |
| Today's Move | -Rs 16.40 (-5.13%) |
| Open | Rs 321.65 |
| High | Rs 321.65 |
| Low | Rs 300.85 |
| Market Capitalisation | Rs 9,191.76 crore |
| Market Cap Category | Mid Cap |
Suven Life Sciences Share Price was last traded at Rs 303.60, below the previous close of Rs 320. The stock opened at Rs 321.65, touched the same level as its day high at Rs 321.65, and slipped to a day low of Rs 300.85 before settling near that lower end of the range. That means Suven Life Sciences Share Price moved Rs 16.40 lower, or 5.13%, during today’s trade.
The pattern is straightforward: Suven Life Sciences Share Price started above the previous close, but the price action did not hold. The share price fall has taken the stock below the Rs 310 mark and keeps it inside a narrow intraday band of just under Rs 21. The market capitalisation of Rs 9,191.76 Cr places Suven Life Sciences in the Mid Cap category, which is the correct size context for reading today’s decline.
According to latest Univest figures, the day’s movement does not establish a company-specific trigger, so the verified price event itself remains the central story. That naturally shifts the discussion to Suven Life Sciences Fundamental Analysis and how the stock stands relative to the healthcare pack.
Suven Life Sciences (SUVEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,191.76 crore |
| P/B Ratio | 16.24x |
| ROE | -101.8% |
| ROCE | -78.71% |
| EPS | Rs -12.47 |
| Book Value Per Share | Rs 19.71 |
| Dividend Yield | 0% |
Suven Life Sciences (SUVEN) fundamental metrics show P/B 16.24x, ROE -101.8%, ROCE -78.71%. Taken on their own, these numbers offer context rather than a trading signal.
Suven Life Sciences has a market capitalisation of Rs 9,191.76 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 16.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -101.8% and ROCE of -78.71%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs -12.47, book value per share of Rs 19.71, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 16.24x |
| Benchmark Median P/B | 2.94x |
| Benchmark Average P/B | 4.37x |
| Company ROE | -101.8% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | -78.71% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 9,191.76 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
| Benchmark Average Market Cap | Rs 14,358.25 crore |
Suven Life Sciences (SUVEN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Suven Life Sciences (SUVEN) has a ROE of -101.8%, which is below the benchmark median of 11.7%, a difference of -970.09%. Suven Life Sciences (SUVEN) has a ROCE of -78.71%, which is below the benchmark median of 13.61%, a difference of -678.32%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Its ROE of -101.8% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at -78.71% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Suven Life Sciences (SUVEN) has a market capitalisation of Rs 9,191.76 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Suven Life Sciences
- Suven Life Sciences Share Price fell 5.13% today and stayed near the lower end of the intraday range.
- The current price of Rs 303.60 is below the previous close of Rs 320.
- The stock is a Mid Cap company with a market capitalisation of Rs 9,191.76 Cr.
- Valuation on P/B at 16.24 is high versus the same-industry benchmark median and several peers.
- ROE of -101.8% and ROCE of -78.71% keep fundamental analysis in focus after today’s decline.
About Suven Life Sciences
Suven Life Sciences operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. The company is known for its presence in drug discovery and related pharmaceutical work, which places Suven Life Sciences Share Price within a specialised part of the healthcare universe. For investors reading Suven Life Sciences Stock News, the key context is that the business is evaluated not just on price movement, but on earnings quality, valuation and return ratios.
In today’s trade, the company remains a Mid Cap name with a market cap of Rs 9,191.76 Cr. That size, combined with the current P/B and negative return ratios, is why Suven Life Sciences Share Price attracts attention even without a fresh company-specific catalyst.
Track Suven Life Sciences Share Price on Univest
Use Suven Life Sciences (SUVEN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Suven Life Sciences Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. Univest also helps readers follow Suven Life Sciences Share Price Today alongside peer comparison, company overview and latest market context. For anyone checking Suven Life Sciences Share Price News or Suven Life Sciences Share Price Update, Univest keeps the data view organised and easy to follow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Suven Life Sciences Share Price fall today?
Ans. Suven Life Sciences Share Price fell 5.13% to Rs 303.60. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move is best read through price action and valuation.
What is Suven Life Sciences Share Price today?
Ans. Suven Life Sciences Share Price is trading at Rs 303.60 as of 01 October 2026 at 1:53:01 PM IST. It is below the previous close of Rs 320 and lower by Rs 16.40 today.
How much did Suven Life Sciences Share Price decline?
Ans. Suven Life Sciences Share Price declined by 5.13% today. In rupee terms, the stock moved down Rs 16.40 from the previous close, while the intraday range stretched from Rs 300.85 to Rs 321.65.
Is Suven Life Sciences a Mid Cap company?
Ans. Yes. Suven Life Sciences Share Price belongs to a Mid Cap company with a market capitalisation of Rs 9,191.76 Cr. That size context is useful when comparing it with broader Healthcare and Pharmaceuticals & Drugs peers.
What does Suven Life Sciences Fundamental Analysis show?
Ans. Suven Life Sciences Fundamental Analysis shows P/B of 16.24, EPS of Rs -12.47, book value of Rs 19.71 and dividend yield of 0. Return ratios are negative, with ROE at -101.8% and ROCE at -78.71%.
How does Suven Life Sciences compare with sector benchmarks?
Ans. Suven Life Sciences Share Price is backed by a P/B of 16.24, above the same-industry benchmark median of 2.94 and average of 4.37. ROE and ROCE are also below the benchmark medians and averages.
Who are the key peers for Suven Life Sciences Share Price?
Ans. Key peers include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla Their P/B and return ratios help frame Suven Life Sciences Share Price within the industry.
Should investors track Suven Life Sciences Share Price on Univest?
Ans. Yes. Univest lets readers track Suven Life Sciences Share Price, key ratios, 52-week levels and peer comparison in one view. That makes it easier to monitor price action, valuation and sector context without guessing.
